BNTC Gene Therapy Penny Stock at All Time Low
BNTC Benitec Biopharma Inc is a development-stage biotechnology company which focuses on the development of novel genetic medicines.
The company develops DNA-directed RNA interference based therapeutics.
BlackRock Inc ., Renaissance Technologies LLC, Vanguard Group Inc. and Morgan Stanley have stakes in it.
On 2/17/2022 P. Trucchio from HC Wainwright brokerage Initiated Coverage for BNTC with a Buy rating and a price target of $10.00.
The price of the stock can easily double in my opinion.
The company develops DNA-directed RNA interference based therapeutics.
BlackRock Inc ., Renaissance Technologies LLC, Vanguard Group Inc. and Morgan Stanley have stakes in it.
On 2/17/2022 P. Trucchio from HC Wainwright brokerage Initiated Coverage for BNTC with a Buy rating and a price target of $10.00.
The price of the stock can easily double in my opinion.
BUY-SELL indicators: https://tradingindicators.store/ ASK FOR A FREE TRIAL!!!
How to install the indicators: https://www.youtube.com/watch?v=VsJ3V3Uczsk&t=2s&ab_channel=TradingIndicators
My Best Stock Picks: https://www.patreon.com/tradingindicators
How to install the indicators: https://www.youtube.com/watch?v=VsJ3V3Uczsk&t=2s&ab_channel=TradingIndicators
My Best Stock Picks: https://www.patreon.com/tradingindicators